Logos Global Management »

Unicycive Therapeutics shares owned by Logos Global Management

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.7M 3.5M 0.50
2024-03-31 $3.0M 3.5M 0.87

More positions owned by Logos Global Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Sarepta Therapeutics (SRPT)
Sarepta Therapeutics Call Option (SRPT)
Apellis Pharmaceuticals Call Option (APLS)
Apellis Pharmaceuticals (APLS)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Structure Therapeutics Sponsored Ads (GPCR)
Ideaya Biosciences (IDYA)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Argenx Se Sponsored Adr (ARGX)
Merus N V (MRUS)
Merus N V (MRUS)
Revolution Medicines (RVMD)

View all positions for Logos Global Management

Top funds holding Unicycive Therapeutics

Octagon Capital Advisors
Dr. Jeffrey R. Jay, M.D.
Logos Global Management
Nantahala Capital Management
Alyeska Investment Group
Vanguard Group
LPL Financial
Geode Capital Management
Goldman Sachs Group
Bleakley Financial Group
BlackRock
BlackRock
State Street Corporation
Jane Street
Northern Trust

View all funds holding Unicycive Therapeutics